Domestic pharma market grew by 6.8% in 2023

The Indian pharmaceutical market (IPM) grew 6.8 per cent to touch a turnover of ~1.93 trillion in calendar year 2023, despite volumes going down marginally by 0.9 per cent. Photograph: Amit......

Time to buy IT and pharma stocks

Since February 26, the BSE IT index has declined 11.3 per cent and the BSE health care index 5.5 per cent. The decline in individual stocks is higher. Infosys, for instance, has declined 19 per......

GSK to spend $904 mn to lift stake in India arm

London-based GlaxoSmithKline on Monday announced a $940-million (Rs 5,220-crore) open offer to raise its stake in its consumer products company in India - GlaxoSmithKline Consumer Healthcare - from......

Novartis-Glaxo deal signals pharma firms don't have it easy

The multi-billion dollar three-way deal of Novartis with  GlaxoSmithKline (GSK) and Eli Lilly is likely to trigger merger control approvals from various anti-trust authorities, including a......